Domestic innovative drug approvals (half year)
RecordSTO-YSAHE1MWZA-G4P4M02KP1-K163HE
China · January–June 2026
Domestic innovative drug approvals in China (half year) were 31 in January–June 2026 (State Council).
New drug approvals in China: every year, the rank and how it is measured
- Publisher
- State Council
- Authority tier
- T1 Official
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
China approved 38 innovative drugs for marketing during the period, including 31 developed by domestic companies, Tao Qing, head of the bureau for operation, monitoring and coordination with the MIIT, told a media conference.
Checked: the figure 31is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
State Council of China. (2026). Value of China's innovative drug out-licensing deals hit new high in H1. Retrieved September 17, 2026, from https://english.www.gov.cn/archive/statistics/202607/20/content_WS6a5de696c6d00ca5f9a0c514.html. Via StatOrigin, https://statorigin.org/stat/stat_YSAHE1MWZAG4P4M02KP1K163HE
Other formats: MLA, Chicago, BibTeX
- MLA
- State Council of China. "Value of China's innovative drug out-licensing deals hit new high in H1." 2026, https://english.www.gov.cn/archive/statistics/202607/20/content_WS6a5de696c6d00ca5f9a0c514.html. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_YSAHE1MWZAG4P4M02KP1K163HE.
- Chicago
- State Council of China. "Value of China's innovative drug out-licensing deals hit new high in H1." 2026. https://english.www.gov.cn/archive/statistics/202607/20/content_WS6a5de696c6d00ca5f9a0c514.html. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_YSAHE1MWZAG4P4M02KP1K163HE.
- BibTeX
- @misc{statecouncil2026domestick163he, author = {{State Council of China}}, title = {Value of China's innovative drug out-licensing deals hit new high in H1}, year = {2026}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_YSAHE1MWZAG4P4M02KP1K163HE}, note = {Original source: https://english.www.gov.cn/archive/statistics/202607/20/content\_WS6a5de696c6d00ca5f9a0c514.html. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- State Council of China · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- Value of China's innovative drug out-licensing deals hit new high in H1
- Type
- Press release
- Published
- —
- Locator
- Value of China's innovative drug out-licensing deals hit new high in H1
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 26 September 2026
- Permanent URL
- /stat/stat_YSAHE1MWZAG4P4M02KP1K163HE